Jægerhusets Tandklinik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  0.0% 0.0% 3.3% 1.7% 1.6%  
Credit score (0-100)  0 0 53 72 74  
Credit rating  N/A N/A BBB A A  
Credit limit (kDKK)  0.0 0.0 0.0 2.5 8.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 6,240 6,807 7,047  
EBITDA  0.0 0.0 625 816 715  
EBIT  0.0 0.0 431 508 468  
Pre-tax profit (PTP)  0.0 0.0 426.6 503.0 460.9  
Net earnings  0.0 0.0 332.8 392.6 357.3  
Pre-tax profit without non-rec. items  0.0 0.0 427 503 461  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 1,573 1,963 1,717  
Shareholders equity total  0.0 0.0 731 1,123 1,480  
Interest-bearing liabilities  0.0 0.0 0.0 895 778  
Balance sheet total (assets)  0.0 0.0 2,925 2,634 2,821  

Net Debt  0.0 0.0 -797 473 -73.6  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 6,240 6,807 7,047  
Gross profit growth  0.0% 0.0% 0.0% 9.1% 3.5%  
Employees  0 0 7 8 8  
Employee growth %  0.0% 0.0% 0.0% 14.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 2,925 2,634 2,821  
Balance sheet change%  0.0% 0.0% 0.0% -10.0% 7.1%  
Added value  0.0 0.0 625.5 702.8 714.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 1,379 82 -493  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 6.9% 7.5% 6.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 14.8% 18.4% 17.3%  
ROI %  0.0% 0.0% 45.9% 32.2% 20.0%  
ROE %  0.0% 0.0% 45.5% 42.4% 27.5%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 25.0% 42.6% 52.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -127.4% 58.0% -10.3%  
Gearing %  0.0% 0.0% 0.0% 79.7% 52.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 2.2% 1.2%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.7 0.5 1.0  
Current Ratio  0.0 0.0 0.7 0.5 1.0  
Cash and cash equivalent  0.0 0.0 797.1 421.5 851.4  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -628.0 -623.2 -20.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 89 88 89  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 89 102 89  
EBIT / employee  0 0 62 64 59  
Net earnings / employee  0 0 48 49 45